发明名称 Controlled release formulation
摘要 The present invention discloses a controlled release formulation suitable for oral administration comprising N<SUP>6</SUP>-cyclopentyl-5'-(N-ethyl)carboxamidoadenosine or a pharmaceutically acceptable salt or ester thereof incorporated in a controlled release matrix. The controlled release formulation of the invention is especially suitable for treating heart rhythm disturbances in a mammal.
申请公布号 US2005118262(A1) 申请公布日期 2005.06.02
申请号 US20040943147 申请日期 2004.09.17
申请人 AURORA JACK;GILL MANMOHAN S.;ONG KENNETH K.H. 发明人 AURORA JACK;GILL MANMOHAN S.;ONG KENNETH K.H.
分类号 A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K36/47;(IPC1-7):A61K31/707;A61K9/22;A61K35/78 主分类号 A61K9/14
代理机构 代理人
主权项
地址